Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis [Phase 3]
Phase 3 trial results show safety and effectiveness of infliximab for treatment of psoriatic arthritis; the study is complete.
-
FDA approval · 2011-02-17FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., signaling a labeling update or expansion of its appro…
-
FDA approval · 2010-12-28FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved Janssen Biotech, Inc.'s supplemental application for infliximab. The approval updates the product's labeling and indications as…
-
CLINICAL_TRIALS trial_result · 2010-12-23Clinical Trial Update: Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis [Phase 3]
Phase 3 double-blind, randomized, placebo-controlled trial of etanercept for psoriatic arthritis and psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia
A completed epidemiology study in Australia evaluated rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; the sponsor Wye…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-22Clinical Trial Update: Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis [Phase 2]
A Phase 2 study comparing abatacept to placebo assessed safety and efficacy in participants with psoriatic arthritis; the trial was terminat…
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Study Evaluating the Safety of Enbrel (Etanercept)
Completed safety-focused clinical trial evaluating Enbrel (etanercept) sponsored by Wyeth (now part of Pfizer) in arthritis and psoriatic ar…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Single Dose PG102 in Patients With Active Psoriatic Arthritis [Phase 1]
A Phase 1 study of a single-dose PG102 in patients with active psoriatic arthritis was terminated; results were posted on 2010-10-15.
-
FDA approval · 2010-07-29FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
FDA approval · 2010-07-29FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc., resulting in an approved amendment to it…
-
FDA approval · 2010-06-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis
The trial evaluating workload, clinical and therapeutic management of psoriatic arthritis has completed, with sponsor Wyeth now a wholly own…
-
FDA approval · 2009-12-30FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis [Phase 4]
A Phase 4 clinical trial evaluating the combination of etanercept and methotrexate for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects [Phase 1, Phase 2]
This update reports the completion of Phase 1 and Phase 2 trials evaluating intra-articular delivery of tgAAC94 for inflammatory arthritis, …
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422) [Phase 3]
This Phase 3 trial update reports results from the RESPOND study evaluating infliximab (Remicade) in methotrexate-naïve psoriatic arthritis …
-
CLINICAL_TRIALS trial_result · 2009-06-18Clinical Trial Update: Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
A Spain-based study evaluating etanercept in rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis has completed; spo…
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis [Phase 4]
Phase 4 trial evaluating etanercept for skin and joint disease in psoriatic arthritis completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
Sponsor Wyeth completed a clinical trial evaluating anxiety and depression in patients with psoriatic arthritis.
-
FDA approval · 2009-05-13FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc.
-
FDA approval · 2009-04-24FDA Approved: SIMPONI — Original Application (Janssen Biotech, Inc.)
FDA approved the original Biologics License Application for Simponi (golimumab) from Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis [Phase 4]
A Phase 4 clinical trial evaluating TNF-α blockade for psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-02Clinical Trial Update: A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM) [Phase 3]
A Canadian Phase 3 open-label study (ACCLAIM) evaluated adding adalimumab to inadequate therapy for psoriatic arthritis, assessing safety an…
-
FDA approval · 2008-04-07FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Orencia (abatacept) submitted by E.R. Squibb & Sons, L.L.C., resulting in an update to its l…
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of adalimumab in patients with moderate to severely active psoriatic arthritis that inade…